View Item 

Show simple item record

Intradermal Anti-Loxosceles Fab Fragments Attenuate Dermonecrotic Arachnidism
dc.contributor.authorGomez, Hernan F.en_US
dc.contributor.authorMiller, Mark J.en_US
dc.contributor.authorTrachy, Joseph W.en_US
dc.contributor.authorMarks, Rory M.en_US
dc.contributor.authorWarren, Jeffrey S.en_US
dc.date.accessioned2010-06-01T20:15:02Z
dc.date.available2010-06-01T20:15:02Z
dc.date.issued1999-12en_US
dc.identifier.citationGomez, Hernan F.; Miller, Mark J.; Trachy, Joseph W.; Marks, Rory M.; Warren, Jeffrey S. (1999). "Intradermal Anti-Loxosceles Fab Fragments Attenuate Dermonecrotic Arachnidism." Academic Emergency Medicine 6(12): 1195-1202. <http://hdl.handle.net/2027.42/73371>en_US
dc.identifier.issn1069-6563en_US
dc.identifier.issn1553-2712en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73371
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10609920&dopt=citationen_US
dc.format.extent132429 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1999 Society for Academic Emergency Medicineen_US
dc.subject.otherLoxoscelesen_US
dc.subject.otherSpideren_US
dc.subject.otherVenomen_US
dc.subject.otherFab Fragmentsen_US
dc.subject.otherArachnidismen_US
dc.titleIntradermal Anti-Loxosceles Fab Fragments Attenuate Dermonecrotic Arachnidismen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Surgery, Section of Emergency Medicine, University of Michigan Medical Center, Ann Arbor, MI.en_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical Center, Ann Arbor, MI.en_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI.en_US
dc.identifier.pmid10609920en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73371/1/j.1553-2712.1999.tb00133.x.pdf
dc.identifier.doi10.1111/j.1553-2712.1999.tb00133.xen_US
dc.identifier.sourceAcademic Emergency Medicineen_US
dc.identifier.citedreferenceLitovitz T. L., Smilkstein M., Felberg L., Klein-Schwartz W., Berlin R., Morgan J. L.. 1996 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1999; 15: 447 – 500.en_US
dc.identifier.citedreferenceAtkins J. A., Wingo C. W., Sodeman W. A., Flynn J. E.. Necrotic arachnidism. Am J Trop Med Hyg. 1958; 7: 165 – 84.en_US
dc.identifier.citedreferenceWasserman G. S., Anderson P. C.. Loxoscelism and necrotic arachnidism. J Toxicol Clin Toxicol. 1983; 21: 451 – 72.en_US
dc.identifier.citedreferenceRees R. S., Nanney L. B., Yates R. A., King L. E.. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism ? J Invest Dermatol. 1984; 83: 270 – 5.en_US
dc.identifier.citedreferenceFutrell J. M.. Loxoscelism. Am J Med Sci. 1992; 304: 261 – 7.en_US
dc.identifier.citedreferenceCaveness W.. Insect bite complicated by fever. Nashville J Med Surg. 1872; 10: 333.en_US
dc.identifier.citedreferenceRees R. S., Altenbem D. P., Lynch J. B.. Brown recluse spider bites: a comparison of early surgical excision and dapsone and delayed surgical excision. Ann Surg. 1985; 20: 2126 – 30.en_US
dc.identifier.citedreferenceSvendsen F. J.. Treatment of clinically diagnosed brown recluse spider bites with hyperbaric oxygen: a clinical observation. J Ark Med Soc. 1986; 83: 199 – 204.en_US
dc.identifier.citedreferenceHobbs G. D., Anderson A. R., Greene T. J., Yealy D. M.. Comparison of hyperbaric oxygen and dapsone therapy for Loxosceles envenomation. Acad Emerg Med. 1996; 3: 758 – 61.en_US
dc.identifier.citedreferencePhillips S., Kohn M., Baker D., et al. Therapy of brown spider envenomation: a controlled trial of hyperbaric oxygen, dapsone and cyproheptadine. Ann Emerg Med. 1995; 25: 363 – 8.en_US
dc.identifier.citedreferenceRees R., Shack R. B., Withers E., Madden J., Franklin J., Lynch J. B.. Management of the brown recluse spider bite. Plast Reconstr Surg. 1981; 68: 768 – 73.en_US
dc.identifier.citedreferenceRees R., Campbell D., Rieger E., King L. E.. The diagnosis and treatment of brown recluse spider bites. Ann Emerg Med. 1987; 16: 945 – 9.en_US
dc.identifier.citedreferenceBravo M., Oviedo I., Farias P., Scheilone H.. Study of anti-Loxosceles serum action on hemolytic and ulcero-necrotic cutaneous effects of Loxosceles laeta venom. Rev Med Chil. 1994; 122: 625 – 9.en_US
dc.identifier.citedreferenceCole H. P., Wesley R. E., King L. E.. Brown recluse envenomation of the eyelid: an animal model. Ophthal Plast Reconstr Surg. 1995; 11: 153 – 64.en_US
dc.identifier.citedreferenceWoolf A. D., Wenger T., Smith T. W., Lovejoy F. H. Jr. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. N Engl J Med. 1992; 326: 1739 – 44.en_US
dc.identifier.citedreferenceBaud F. J., Sabouraud A., Vicaut E., et al. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments. N Engl J Med. 1995; 332: 642 – 5.en_US
dc.identifier.citedreferencePentel P. R., Scarlett W., Ross C. A., Landon J., Sidka A., Keyler D. E.. Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragments. Ann Emerg Med. 1997; 26: 334 – 41.en_US
dc.identifier.citedreferenceValentine J. L., Mayersohn M., Wessinger W. D., Arnold L. W., Owens S. M.. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharm Exp Ther. 1996; 278: 709 – 16.en_US
dc.identifier.citedreferenceDart R. C., Seifert S. A., Carroll L., et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997; 30: 33 – 9.en_US
dc.identifier.citedreferenceClark R. F., Williams S. R., Nordt S. P., Boyer-Hassen L. V.. Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med. 1997; 30: 54 – 7.en_US
dc.identifier.citedreferenceButler V. P., Schmidt D. H., Smith T. W., Haber E., Raynor B. D., Demartini P.. Effects of sheep digoxin: specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. J Clin Invest. 1977; 59: 345 – 59.en_US
dc.identifier.citedreferenceLloyd B. L., Smith T. W.. Contrasting rates of reversal of digoxin toxicity by digoxin: specific IgG and Fab fragments. Circulation. 1978; 58: 280 – 3.en_US
dc.identifier.citedreferenceSmith T. W., Lloyd B. L., Spicer N., Haber E.. Immunogenicity and kinetics of distribution and elimination of sheep digoxin specific IgG and Fab fragments in the rabbit and baboon. Clin Exp Immunol. 1979; 36: 384 – 96.en_US
dc.identifier.citedreferenceGoding J. W.. Use of staphylococcal protein A as an immunological reagent. J Immunol Meth. 1976; 20: 241 – 53.en_US
dc.identifier.citedreferenceCoulter A. R., Harris R. D., Sutherland S. K.. Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom. Med J Aust. 1980; 1: 423 – 5.en_US
dc.identifier.citedreferenceGomez H. F., Miller M. J., Warren J. S.. Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species [abstract]. Acad Emerg Med. 1999; 6: 378.en_US
dc.identifier.citedreferenceCoulter A. R., Harris R.. Simplified preparation of rabbit Fab fragments. J Immunol Meth. 1983; 59: 199 – 203.en_US
dc.identifier.citedreferenceSmith J. A.. Antibody-sandwich ELISA to detect soluble antigens. In: Ausubel F. M., Brent R., Kingston R. E., et al. (eds). Current Protocols in Molecular Biology. New York: Wiley, 1993, p 11.2.8.en_US
dc.identifier.citedreferencePatel K. D., Modur V., Zimmerman G. A., Prescott S. M., McIntyre T. M.. The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. J Clin Invest. 1994; 94: 631 – 42.en_US
dc.identifier.citedreferenceMiller M., Gomez H. F., Huang X., Warren J. S.. In vivo analysis of Loxosceles envenomation and the mediators of dermonecrotic development [abstract]. FASEB J. 1998; 12: 184.en_US
dc.identifier.citedreferenceHebert C. A., Baker J. B.. Interleukin-8: a review. Cancer Invest. 1993; 11: 743 – 50.en_US
dc.identifier.citedreferenceRampart M., Van Damme J., Zonnekeyn L., Herman A. G.. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol. 1989; 135: 21 – 5.en_US
dc.identifier.citedreferenceFolkesson H. G., Matthay M. A., Hebert C. A., Broaddus C. V.. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest. 1995; 96: 107 – 16.en_US
dc.identifier.citedreferenceBroaddus V. C., Boylan A. M., Hoeffel J. M., et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol. 1994; 152: 2960 – 7.en_US
dc.identifier.citedreferenceMeyer W. P., Habib A. G., Onayade A. A., et al. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg. 1977; 56: 291 – 300.en_US
dc.identifier.citedreferenceKarlson-Stiber C., Persson H., Heath A., Smith D., Al-Abulla I. H., Sjostrom L.. First clinical experiences with specific sheep Fab fragments in snakebite. Report of a multicentre study of Vipera berus envenoming. J Intern Med. 1997; 241: 53 – 8.en_US
dc.identifier.citedreferenceLicea A. F., Becerril B., Possani L. D.. Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann. Toxicon. 1996; 34: 843 – 7.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1553-2712.1999.tb00133.x.pdf
Size:
129.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.